MDXG

Q: What is the price of MiMedx Group (MDXG) today?

The price of MiMedx Group (MDXG) today is $ 3.95, with return of -48.03% compared to the last year. The price of MiMedx Group (MDXG) started the year trading around $ 6.77 and today it is at $ 3.95. Follow the real-time price chart, the historical price of MiMedx Group (MDXG) and international markets.

Q: When does MiMedx Group (MDXG) pay dividends?

MiMedx Group (MDXG) did not distribute dividends in the last year.

Q: Is MiMedx Group (MDXG) worth it?

Currently, MiMedx Group (MDXG) is priced at $ 3.95, with a P/E of 11.61%, representing a deviation of 6,279% from its historical average P/E. In the last year, the stock showed a variation of -48.03 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -48.03%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy MiMedx Group (MDXG) stock?

Investing in stocks of MiMedx Group (MDXG) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of MiMedx Group (MDXG) yield today?

The yield of MiMedx Group (MDXG) was -19.22% in the last month, -48.03% in the last year and -65.17% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of MiMedx Group (MDXG) today, the total investment would be $ 395.00, based on the current price of $ 3.95.If past performance were to repeat, the return on your investment would be:In 1 year: $ 205.28In 5 years: $ 137.58In 10 years: $ 174.71It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

MiMedx Group Inc.

Price

$ 3.95

return (12m)

-48.03%

p/e

11.61

p/bv

2.20

DIVIDEND YIELD

0.00%

MDXG price

MDXG

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment MDXG

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-19.22%

3 months

-41.65%

1 year

-48.03%

2 years

-48.70%

5 years

-65.17%

10 years

-55.77%

Fundamentals MDXG

review the fundamentals of MiMedx Group shares

P/E

11.61

Sector: -2.04 Industry: -5.48

P/S (PSR)

1.35

Sector: 1.88 Industry: 2.88

P/BV

2.20

Sector: 2.11 Industry: 2.07

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

14.18%

Sector: -25.47% Industry: -47.59%

ROE

18.94%

Sector: -29.41% Industry: -43.15%

ROIC

38.75%

Sector: -411.21% Industry: -461.26%

NET MARGIN

11.60%

Sector: -28.27% Industry: -33.57%

GROSS MARGIN

82.56%

Sector: 44.66% Industry: 45.25%

OPERATING MARGIN

15.26%

Sector: -23.29% Industry: -29.30%

EV/EBITDA

7.08

Sector: -0.79 Industry: -3.70

EV/EBIT

8.71

Sector: -2.18 Industry: -5.34

PRICE-TO-ASSETS

1.65

Sector: 1.13 Industry: 1.26

BVPS

1.73

Sector: 3.60 Industry: 1.97

EPS

0.33

Sector: -0.89 Industry: -1.31

EQUITY-TO-ASSETS RATIO

0.75

Sector: 0.43 Industry: 0.47

LIABILITIES / ASSETS

0.25

Sector: 0.47 Industry: 0.42

CAGR REVENUE 5 YEARS

11.58%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF MiMedx Group ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 3.95

Fair Value

$ 0.00

Upside/Downside Return potential.

-9.27%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals MDXG

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	38.09	32.96	86.53%	0.71%	$ 786.02 B	31.66%
ISRG	56.27	8.96	15.92%	0.00%	$ 160.69 B	28.38%
TMO	26.55	3.32	12.52%	0.36%	$ 177.98 B	15.05%
SNY	12.52	1.36	10.86%	4.73%	$ 114.19 B	18.68%
NVS	20.29	6.10	30.04%	4.71%	$ 283.76 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.24	2.27	9.38%	3.25%	$ 111.80 B	13.00%
CVS	50.34	1.18	2.35%	3.80%	$ 89.00 B	0.44%
GSK	14.19	5.07	35.71%	3.10%	$ 108.22 B	17.48%
BSX	35.40	0.00	0.00%	0.00%	$ 102.58 B	14.44%
TMDX	17.70	7.12	40.22%	0.00%	$ 3.37 B	31.43%
HCA	15.86	-38.82	-244.82%	0.61%	$ 107.58 B	8.97%
IDXX	42.16	27.82	65.99%	0.00%	$ 44.67 B	24.62%
RMD	21.66	5.09	23.51%	1.06%	$ 32.19 B	27.53%
DHR	35.51	2.44	6.88%	0.71%	$ 128.33 B	14.71%
INMD	9.00	1.24	13.73%	0.00%	$ 844.20 M	25.32%
PHG	24.55	1.98	8.06%	3.31%	$ 25.47 B	5.07%
FMS	11.18	0.75	6.75%	3.57%	$ 12.62 B	5.02%
SYK	38.64	5.59	14.48%	1.04%	$ 125.41 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

MDXG Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT MiMedx Group

MiMedx Group Inc.

Average Investor10 user rating

4.0 (1 people)

United States

18 years

Founded: 2008

2007

Time since IPO - 19 years

735

Employees

The Company MiMedx Group Inc. (United States), is listed on Nasdaq with a market value of $ 563.88 Millions, having an equity of $ 256.55 Millions.

With a total of 735 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.

In the last 12 months the Company had a revenue of $ 418.62 Millions, which generated a profit in the amount of $ 48.58 Millions.

As for its main indicators, the Company has a P/E ratio of 11.61, a P/BV ratio of 2.20 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker MDXG.

Market cap

$ 563.88 Millions

Net worth

$ 256.55 Millions

US$ 256,550,000.00

Assets

$ 342.65 Millions

US$ 342,650,000.00

Total Shares Outstanding

148.00 Millions

148,000,000

Average Daily Trading Volume

$ 1.02 Million

US$ 1,019,576.46

Sector

Health

Industry

Medical Supplies and Equipment

MDXG

MDXG revenue and profits

Financial Results MDXG

DRAG THE FRAME TO SEE MORE DATA

MDXG cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 71.82 10,73% (12M)

P/E

50.34

3.80%

ROE

2.35%

P/BV

1.18

CI - Cigna

$ 266.75 --17,71% (12M)

P/E

10.14

2.32%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 32.74 --45,84% (12M)

P/E

-2.36

0.00%

ROE

-33.28%

P/BV

0.79

HUM - Humana

$ 173.39 --33,25% (12M)

P/E

17.08

2.09%

ROE

6.70%

P/BV

1.14

HCA - HCA Healthcare

$ 473.24 37,82% (12M)

P/E

15.86

0.61%

ROE

-244.82%

P/BV

-38.82

LLY - Eli Lilly

$ 919.77 13,23% (12M)

P/E

38.09

0.71%

ROE

86.53%

P/BV

32.96

NVS - Novartis

$ 152.75 47,20% (12M)

P/E

20.29

4.71%

ROE

30.04%

P/BV

6.10